Should You Buy Centrus Energy While It's Below $270?

Surging U.S. electricity demand from electrification and AI (Bank of America projects ~2.5% CAGR) and nuclear’s role as the largest low‑carbon source (18% of U.S. power) have renewed interest in the fuel supply chain, putting Centrus Energy—an LEU seller and the only NRC‑licensed HALEU producer outside Russia with proven enrichment technology—in a potentially pivotal position. Centrus currently relies on imports (including a commercial agreement with a Russian entity) and holds a DOE waiver to import LEU for 2026–27, but a planned phase‑in of a Russian LEU import ban by 2028 (affecting roughly 25% of supply) creates urgency for domestic HALEU/LEU production; Centrus’ plan to expand its Piketon, Ohio facility to produce HALEU/LEU hinges on DOE funding, private investment and long‑term offtakes, while commercial HALEU reactors aren’t expected until the late 2020s/early 2030s. The stock has been highly volatile ($50–$464 range this year, down ~47% from its 52‑week high) and remains expensive at ~48.6x projected EPS, reflecting investor optimism but substantial execution and timing risk that could produce large swings in returns.

Analysis

U.S. electricity demand is projected to grow roughly 2.5% CAGR, driven by electrification and AI, and nuclear already supplies 18% of U.S. power, which explains renewed investor interest in the fuel-supply chain. Centrus Energy (LEU) is a central player: its revenue is concentrated in low-enriched uranium (LEU) sales and it operates an advanced enrichment/technical solutions segment that includes a Department of Energy (DOE) HALEU contract.

Centrus is the only NRC‑licensed HALEU producer outside Russia and the sole U.S. company with proven enrichment technology, which Stifel characterizes as "uniquely positioned." The company currently imports LEU (including a commercial agreement with TEXEX) under a DOE waiver permitting imports for 2026–2027, but a planned full phase‑in of a Russian LEU import ban by 2028 would require replacement of roughly 25% of current supply.

The investment case hinges on successful expansion of enrichment capacity at the Piketon, Ohio plant, which requires DOE funding, private capital and long‑term customer commitments; commercial HALEU reactors are not expected until the late 2020s/early 2030s. The stock has been highly volatile (this year’s range $50–$464, now ~47% below its 52‑week high) and trades at ~48.6x projected EPS (versus a prior peak near 88x), reflecting optimism but significant timing and execution risk.

Key Decisions for Investors

• Initiate only a small, tactical position to capture upside from domestic HALEU/LEU progress while limiting capital at risk given high valuation and execution uncertainty
• Require concrete catalysts (DOE funding approval for Piketon, signed long‑term offtake contracts, or firm timelines around the 2028 Russian LEU import phase‑in) before materially increasing exposure
• Use position sizing or option hedges because the stock has shown extreme volatility ($50–$464 this year) and trades at ~48.6x projected EPS, making it sensitive to timing and execution news
• Monitor HALEU commercial reactor commercialization (late 2020s/early 2030s) and competitors (TerraPower, Kairos Power, Westinghouse, Oklo) as demand validation events that would justify a longer‑term overweight